Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information
From Elite Pharmaceuticals, Inc.
Via AccessWire
Tickers ELTP
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
From Elite Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers ELTP
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information
From Elite Pharmaceuticals, Inc.
Via AccessWire
Tickers ELTP
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022
From Elite Pharmaceuticals, Inc.
Via AccessWire
Tickers ELTP
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year Ended September 30, 2021 and Provides Conference Call Information
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
From Elite Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Tickers ELTP
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.